TinyRx is a technology company.
TinyRx has raised $8.0M across 2 funding rounds.
TinyRx has raised $8.0M in total across 2 funding rounds.
TinyRx is a San Francisco-based technology company that operates as an on-demand prescription delivery service. It enables users to have their existing prescriptions delivered to any location they choose, focusing on convenience and cost savings. TinyRx serves patients primarily in the San Francisco Bay Area, partnering with local pharmacies to provide faster, more affordable access to medications. The company addresses the problem of expensive and inconvenient prescription fulfillment by leveraging coupon deals and manufacturer rebates to find the best prices for customers. Its business model includes revenue sharing with local pharmacies and charging users a fee for express delivery, positioning itself as a competitive alternative to large pharmacy chains and other delivery startups[1][2][4].
Founded around 2014 and incorporated in 2015, TinyRx was co-founded by Christopher Bockman and Andrew Lockhart, among others, with backgrounds linked to tech startups and healthcare innovation. The idea emerged from recognizing the inefficiencies and high costs in the pharmaceutical industry, particularly the lack of patient-centric pharmacy experiences dominated by large chains with conflicting interests. Early traction included beta testing with Bay Area physicians and pharmacies, and securing $5 million in seed funding from investors such as Google Ventures, Eight Partners, and Stanford’s StartX. This funding supported its initial launch and plans to expand beyond the Bay Area[1][2][5].
TinyRx rides the growing trend of digital health and on-demand delivery services, capitalizing on increasing consumer demand for convenience and cost transparency in healthcare. The timing aligns with rising prescription drug prices and a fragmented pharmacy market dominated by large chains, creating an opportunity for tech-enabled startups to disrupt traditional models. By integrating technology with local pharmacy networks, TinyRx contributes to a more competitive and patient-focused ecosystem, potentially influencing how prescriptions are fulfilled and delivered nationwide. Its approach also reflects broader shifts toward personalized healthcare services and leveraging data for cost savings[1][2].
Looking ahead, TinyRx’s success depends on expanding its geographic footprint beyond the Bay Area and scaling its technology platform, including mobile apps. Trends such as telemedicine growth, increased digital health adoption, and consumer demand for price transparency will shape its trajectory. If it can maintain strong local partnerships and continue to optimize pricing, TinyRx could evolve into a significant player in prescription delivery, challenging incumbents and improving patient access. However, competition from well-funded rivals like PillPack and Zipdrug will require continuous innovation and operational excellence. Its influence may grow as it helps redefine pharmacy delivery as a tech-enabled, patient-first service[1][2][4].
TinyRx has raised $8.0M in total across 2 funding rounds.
TinyRx's investors include 7percent Ventures, Altair Capital Management, Amplify Partners, Anorak Ventures, Asset Management Ventures, Catapult Capital, F-Prime Capital Partners, Fusion Fund, Future Perfect Ventures, Goodwater Capital, Gotham Gal Ventures, Great Oaks Venture Capital.
TinyRx has raised $8.0M across 2 funding rounds. Most recently, it raised $5.0M Venture Round in November 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2015 | $5.0M Venture Round | 7percent Ventures, Altair Capital Management, Amplify Partners, Anorak Ventures, Asset Management Ventures, Catapult Capital, F-Prime Capital Partners, Fusion Fund, Future Perfect Ventures, Goodwater Capital, Gotham Gal Ventures, Great Oaks Venture Capital, Hauser Ventures, Jlabs, KRM Interests LLC, Scout Ventures, Seven Seven Six, Streamlined Ventures, TMV, Uncork Capital, Winklevoss Capital, Y Combinator, Andrew Ferenci, Ben Lin, Brian Sugar, Gokul Rajaram, Josh Spear, Michael Levit, Mike Greenfield, Scott Tannen | |
| May 1, 2015 | $3.0M Seed | AiSprouts VC, Hoxton Ventures, Jude Gomila Rolling Fund, Marathon Venture Capital, New Enterprise Associates, Quiet Capital, Gil Penchina, Unpopular Ventures, Winklevoss Capital |